Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2017, Article ID 4580967, 5 pages
https://doi.org/10.1155/2017/4580967
Case Report

Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab

1Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, Nagoya, Japan
2Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Correspondence should be addressed to Taio Naniwa; pj.ca.uc-ayogan.dem@awinant

Received 15 March 2017; Accepted 18 May 2017; Published 6 June 2017

Academic Editor: Gregory J. Tsay

Copyright © 2017 Shiho Iwagaitsu and Taio Naniwa. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Keser, H. Direskeneli, and K. Aksu, “Management of Takayasu arteritis: a systematic review,” Rheumatology, vol. 53, no. 5, Article ID ket320, pp. 793–801, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Marquez, D. Flores, L. Candia, and L. R. Espinoza, “Granulomatous vasculitis,” Current Rheumatology Reports, vol. 5, no. 2, pp. 128–135, 2003. View at Publisher · View at Google Scholar
  3. M. Noris, E. Daina, S. Gamba, S. Bonazzola, and G. Remuzzi, “Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?” Circulation, vol. 100, no. 1, pp. 55–60, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Park, S. W. Lee, Y. B. Park, and S. K. Lee, “Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis,” Rheumatology, vol. 45, no. 5, pp. 545–548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Salvarani, F. Cantini, L. Boiardi, and G. G. Hunder, “Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis,” Clinical and Experimental Rheumatology, vol. 21, Supplement 32, no. 6, pp. S23–S28, 2003. View at Google Scholar · View at Scopus
  6. Y. Seko, O. Sato, A. Takagi et al., “Restricted usage of T-cell receptor Vα-Vβ genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis,” Circulation, vol. 93, no. 10, pp. 1788–1790, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Mekinian, C. Comarmond, M. Resche-Rigon et al., “Efficacy of biological–targeted treatments in takayasu arteritis: multicenter, retrospective study of 49 patients,” Circulation, vol. 132, no. 18, pp. 1693–1700, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Tombetti, S. Franchini, M. Papa, M. G. Sabbadini, and E. Baldissera, “Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center,” The Journal of Rheumatology, vol. 40, no. 12, pp. 2047–2051, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Bottazzi, A. Doni, C. Garlanda, and A. Mantovani, “An integrated view of humoral innate immunity: pentraxins as a paradigm,” Annual Review of Immunology, vol. 28, pp. 157–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ishihara, G. Haraguchi, T. Kamiishi, D. Tezuka, H. Inagaki, and M. Isobe, “Sensitive assessment of activity of takayasu's arteritis by pentraxin3, a new biomarker,” Journal of the American College of Cardiology, vol. 57, no. 16, pp. 1712-1713, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Uchida, N. Matsukawa, T. Oguri et al., “Reversible cerebral vasoconstriction syndrome in a patient with Takayasu's arteritis,” Internal Medicine, vol. 50, no. 15, pp. 1611–1614, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Yamasaki, M. Kurimura, T. Kasai, M. Sagara, T. Kodama, and K. Inoue, “Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations,” Clinical Chemistry and Laboratory Medicine, vol. 47, no. 4, pp. 471–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Salvarani, L. Magnani, M. Catanoso et al., “Rescue treatment with tocilizumab for takayasu arteritis resistant to TNF-α blockers,” Clinical and Experimental Rheumatology, vol. 30, no. 70, pp. S90–S93, 2012. View at Google Scholar · View at Scopus
  14. M. Bredemeier, C. M. Rocha, M. V. Barbosa, and E. H. Pitrez, “One–year clinical and radiological evolution of a patient with refractory Takayasu's arteritis under treatment with tocilizumab,” Clinical and Experimental Rheumatology, vol. 30, no. 70, pp. S98–S100, 2012. View at Google Scholar · View at Scopus
  15. L. Dagna, F. Salvo, M. Tiraboschi et al., “Pentraxin-3 as a marker of disease activity in takayasu arteritis,” Annals of Internal Medicine, vol. 155, no. 7, pp. 425–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Misra, D. Danda, S. M. Rajappa et al., “Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS '10),” Rheumatology, vol. 52, no. 10, pp. 1795–1801, 2013. View at Publisher · View at Google Scholar
  17. N. Nishimoto, K. Terao, T. Mima, H. Nakahara, N. Takagi, and T. Kakehi, “Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease,” Blood, vol. 112, no. 10, pp. 3959–3964, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Alibaz-Oner, K. Aksu, S. P. Yentur, G. Keser, G. Saruhan-Direskeneli, and H. Direskeneli, “Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow–up,” Clinical and Experimental Rheumatology, vol. 34, pp. S73–S76, 2016. View at Google Scholar · View at Scopus
  19. D. Tezuka, G. Haraguchi, T. Ishihara et al., “High Standardized Uptake Value of 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography was correlated with Disease Activity in Patients with Takayasu Arteritis,” Circulation, vol. 122, article A15229, 2010. View at Google Scholar